access+affordability

10% have skipped prescribed dosages to preserve drugs and save money.

This international, cross-sectional survey was developed by investigators from a range of clinical practice settings across low-income to high-income countries, including members of the WHO Essential Medicines Cancer Working Group.

Making the prices of medicines more transparent around the world would appear to be a positive force for patients.

Many medical professionals look to biosimilar drugs as a way to increase competition and give consumers cheaper options, much as generic drugs do, and they point to the more robust use of these products in Europe to cut costs.

At the technical briefing, a new vision for collaboration between the public and private sectors was put forward to provide better access to safe, effective, novel, high-priced medicines.

Biosimilars are cheaper versions of biologic drugs made from living organisms.

The U.N.-backed vaccine program is so far behind schedule that not even 10 percent of the population in poor countries is fully vaccinated, experts say.

The program was created by the U.S. Congress in 1992.

Undeniably, COVID19 illustrates and emphasizes the urgent need to further increase transparency in pharmaceuticals, and to strengthen collaboration amongst Member States.

The American health care system is built on the idea that a pill is a pill. Generic drugs are considered equal to and interchangeable with one another — and also with the name brand.

The purchase was to be announced early next week to coincide with the United Nations General Assembly meeting in New York.

The list price for Trikafta in the U.S. is $310,000, meaning paying to fund the drug for one patient in Canada could be more than $400,000 a year.

Man previously denied new cystic fibrosis drug by Canada Life approved by different insurance company.

The drive to produce vaccines in Africa is designed to help more developing countries access COVID-19 shots after rich nations bought up most of this year's supply.

CNBC's Meg Tirrell joins Shep Smith to discuss Americans' attitude toward vaccines as well as treatments like monoclonal antibodies.